window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-B38694VDQ5');
Skip to main content

KENNESAW, GA (August 2, 2021) – Deerland Probiotics & Enzymes has announced the publication of a new study that is the first of its kind to directly investigate the germination of a spore-forming probiotic strain in the human small intestines. The study, entitled Presence and germination of the probiotic Bacillus subtilis DE111® in the human small intestinal tract, has been published in Frontiers in Microbiology.

continue at deerland.com

More Resources

Human Clinical Study: DE111 Supports Digestion
A clinical study evaluating the effect of DE111 on digestive health resulted in a significant influence on gut microbiota measured…
More
Deerland’s DE111 Probiotic Supports Regularity, According to Study
Researchers have found that consumption of Deerland Probiotics & Enzymes’ probiotic strain DE111 can improve occasional constipation and/or diarrhea in…
More
DE111 Probiotic Provides Benefits for Body Fat Percentage and Athletic Performance, According to Latest Study
Researchers have found that consumption of the probiotic strain DE111 in conjunction with adequate post-workout nutrition can improve body composition…
More